T&L Co., Ltd. (KOSDAQ:340570)

South Korea flag South Korea · Delayed Price · Currency is KRW
59,400
+200 (0.34%)
At close: Aug 14, 2025, 3:30 PM KST
0.34%
Market Cap479.48B
Revenue (ttm)201.39B
Net Income (ttm)55.16B
Shares Out8.07M
EPS (ttm)6,833.19
PE Ratio8.69
Forward PE7.63
Dividend750.00 (1.27%)
Ex-Dividend DateDec 27, 2024
Volume36,235
Average Volume42,493
Open58,700
Previous Close59,200
Day's Range58,600 - 59,500
52-Week Range56,700 - 85,600
Beta0.16
RSI48.74
Earnings DateAug 14, 2025

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1998
Employees 142
Stock Exchange KOSDAQ
Ticker Symbol 340570
Full Company Profile

Financial Performance

In 2024, T&L Co., Ltd.'s revenue was 174.89 billion, an increase of 51.47% compared to the previous year's 115.46 billion. Earnings were 46.41 billion, an increase of 69.13%.

Financial Statements

News

There is no news available yet.